Farzad S. Alinaghi
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Journal: American journal of clinical dermatology
Published: May 05, 2026
Effectiveness and Safety of Delgocitinib Cream in Pustulosis Palmoplantaris: A Case Series.
Journal: Acta dermato-venereologica
Published: July 30, 2025
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis.
Journal: American journal of clinical dermatology
Published: July 06, 2025
Risk of Dyslipidemia Associated With Oral Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Journal: International journal of dermatology
Published: June 23, 2025
Palmoplantar pustulosis is associated with greater burden and impaired quality of life compared to psoriasis only: findings from a cross-sectional study within the Danish Skin Cohort.
Journal: Journal of the American Academy of Dermatology
Published: June 07, 2025
Prevalence of Contact Allergy to Rubber Accelerators From the European Baseline Series in Dermatitis Patients: A Systematic Review and Meta-Analysis.
Journal: Contact dermatitis
Published: April 24, 2025
A First Case of Complete Resolution of Hair Loss in a Patient With Rheumatoid Arthritis and Concomitant Alopecia Universalis Treated With Filgotinib.
Journal: International journal of dermatology
Published: January 29, 2025
Prevalence of Contact Allergy to Neomycin in Dermatitis Patients: A Systematic Review and Meta-Analysis.
Journal: Contact dermatitis
Published: December 17, 2024
Prevalence of risk factors affecting the use of oral JAK inhibitors in hidradenitis suppurativa.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 13, 2024
Risk of infections during treatment with oral Janus kinase inhibitors in randomized placebo-controlled trials: A systematic review and meta-analysis.
Journal: JAAD international
Published: September 09, 2024
Last Updated: 09/26/2026